152 related articles for article (PubMed ID: 25771379)
1. Chemistry and bifunctional chelating agents for binding (177)Lu.
Parus JL; Pawlak D; Mikolajczak R; Duatti A
Curr Radiopharm; 2015; 8(2):86-94. PubMed ID: 25771379
[TBL] [Abstract][Full Text] [Related]
2. A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for
Pandey U; Gamre N; Lohar SP; Dash A
Appl Radiat Isot; 2017 Sep; 127():1-6. PubMed ID: 28478331
[TBL] [Abstract][Full Text] [Related]
3. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
4. Homologous Structural, Chemical, and Biological Behavior of Sc and Lu Complexes of the Picaga Bifunctional Chelator: Toward Development of Matched Theranostic Pairs for Radiopharmaceutical Applications.
Vaughn BA; Koller AJ; Chen Z; Ahn SH; Loveless CS; Cingoranelli SJ; Yang Y; Cirri A; Johnson CJ; Lapi SE; Chapman KW; Boros E
Bioconjug Chem; 2021 Jul; 32(7):1232-1241. PubMed ID: 33284001
[TBL] [Abstract][Full Text] [Related]
5. What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.
Price EW; Zeglis BM; Cawthray JF; Lewis JS; Adam MJ; Orvig C
Inorg Chem; 2014 Oct; 53(19):10412-31. PubMed ID: 25192223
[TBL] [Abstract][Full Text] [Related]
6. Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with
Chong HS; Chen Y; Kang CS; Sin I; Zhang S; Wang H
J Inorg Biochem; 2021 Aug; 221():111436. PubMed ID: 33971521
[TBL] [Abstract][Full Text] [Related]
7. Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225.
Cieslik P; Kubeil M; Zarschler K; Ullrich M; Brandt F; Anger K; Wadepohl H; Kopka K; Bachmann M; Pietzsch J; Stephan H; Comba P
J Am Chem Soc; 2022 Nov; 144(47):21555-21567. PubMed ID: 36382991
[TBL] [Abstract][Full Text] [Related]
8. Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry.
Choudhary N; Dimmling A; Wang X; Southcott L; Radchenko V; Patrick BO; Comba P; Orvig C
Inorg Chem; 2019 Jul; 58(13):8685-8693. PubMed ID: 31247868
[TBL] [Abstract][Full Text] [Related]
9. Estimation of specific activity of 177Lu by 'saturation assay' principle using DOTA as ligand.
Pillai AM; Chakraborty S; Das T
Curr Radiopharm; 2015; 8(2):123-8. PubMed ID: 25771375
[TBL] [Abstract][Full Text] [Related]
10. Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and acyclic ligands.
Stimmel JB; Kull FC
Nucl Med Biol; 1998 Feb; 25(2):117-25. PubMed ID: 9468026
[TBL] [Abstract][Full Text] [Related]
11. Exploring Aqueous Coordination Chemistry of Highly Lewis Acidic Metals with Emerging Isotopes for Nuclear Medicine.
Whetter JN; Śmiłowicz D; Boros E
Acc Chem Res; 2024 Mar; 57(6):933-944. PubMed ID: 38501206
[TBL] [Abstract][Full Text] [Related]
12. Rapid Thermodynamically Stable Complex Formation of [
Kostelnik TI; Wang X; Southcott L; Wagner HK; Kubeil M; Stephan H; Jaraquemada-Peláez MG; Orvig C
Inorg Chem; 2020 May; 59(10):7238-7251. PubMed ID: 32337985
[TBL] [Abstract][Full Text] [Related]
13. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates.
Li WP; Ma DS; Higginbotham C; Hoffman T; Ketring AR; Cutler CS; Jurisson SS
Nucl Med Biol; 2001 Feb; 28(2):145-54. PubMed ID: 11295425
[TBL] [Abstract][Full Text] [Related]
14. Indirect Production of No Carrier Added (NCA) (177)Lu from Irradiation of Enriched (176)Yb: Options for Ytterbium/Lutetium Separation.
Dash A; Chakravarty R; Knapp FF; Pillai AM
Curr Radiopharm; 2015; 8(2):107-18. PubMed ID: 25771377
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
Kang CS; Chen Y; Lee H; Liu D; Sun X; Kweon J; Lewis MR; Chong HS
Nucl Med Biol; 2015 Mar; 42(3):242-9. PubMed ID: 25487552
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a stabilized 177Lu-siRNA complex and evaluation of its stability and RNAi activity.
Fathi M; Yavari K; Taghikhani M; Ghannadi Maragheh M
Nucl Med Commun; 2015 Jun; 36(6):636-45. PubMed ID: 25759946
[TBL] [Abstract][Full Text] [Related]
17. Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals.
Price EW; Cawthray JF; Adam MJ; Orvig C
Dalton Trans; 2014 May; 43(19):7176-90. PubMed ID: 24676528
[TBL] [Abstract][Full Text] [Related]
18. The effect of chelator type on in vitro receptor binding and stability in 177Lu-labeled cetuximab and panitumumab.
Novy Z; Laznickova A; Mandikova J; Barta P; Laznicek M; Trejtnar F
J Labelled Comp Radiopharm; 2014 Jun; 57(7):448-52. PubMed ID: 24889367
[TBL] [Abstract][Full Text] [Related]
19. Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
Chong HS; Ma X; Le T; Kwamena B; Milenic DE; Brady ED; Song HA; Brechbiel MW
J Med Chem; 2008 Jan; 51(1):118-25. PubMed ID: 18062661
[TBL] [Abstract][Full Text] [Related]
20. Functionally Versatile and Highly Stable Chelator for
Li L; Jaraquemada-Peláez MG; Kuo HT; Merkens H; Choudhary N; Gitschtaler K; Jermilova U; Colpo N; Uribe-Munoz C; Radchenko V; Schaffer P; Lin KS; Bénard F; Orvig C
Bioconjug Chem; 2019 May; 30(5):1539-1553. PubMed ID: 31009566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
